IT
22
Projects
3
Coordinated
14
As Partner
€1,547,059
Total Budget
Budget Range
Min
€2,455
Average
€70,321
Max
€243,071
Role Distribution
Sector Distribution
Budget by Sector (€)
Projects (22)
P
IMAGING AND ADVANCED GUIDANCE FOR WORKFLOW OPTIMIZATION IN INTERVENTIONAL ONCOLOGY
Health101112053
€243,071
P
Validated non-invasive liquid biopsy tests for cancer PREDIction in LYNCH Syndrome
HORIZON.2.1101213916
€136,063
C
Quality of Life in Oncology: measuring what matters for cancer patients and survivors in Europe
Health101096362
€106,073
C
Integrative science, Intelligent data platform for Individualized LUNG cancer care with Immunotherapy
Health101057695
€99,967
P
COMPREHENSIVE CANCER INFRASTRUCTURES 4 EUROPE
Health101103746
€99,841
C
Intelligent Ecosystem to improve the governance, the sharing and the re-use of health Data for Rare Cancers
Health101057048
€81,905
P
Novel health care strategies for melanoma in children, adolescents and young adults
Health101096667
€80,132
P
THE STRONG-AYA INITIATIVE: IMPROVING THE FUTURE OF YOUNG ADULTS WITH CANCER
Health101057482
€72,350
P
Prediction and prevention of late effects in AYA cancer survivors – An effort to understand, predict and prevent late effects in AYAs 15-39 years of age, with a focus on fertility and gonadal toxicity
Health101214879
€63,291
P
Understanding and addressing LATE-effects of treatment of AYA cancer survivors with AI-based digital phenotyping and non-invasive holistic approach
Health101214326
€62,397
P
Establishing of Cancer Mission Hubs: Networks and Synergies
Health101104587
€60,961
P
Co-creation and implementation of an intervention to improve the understanding of TesticulaR cANcer late effects and unmet Supportive CarENeeDs of AYA survivors using eXtended Reality.
Health101214413
€60,039
P
Implementation and evaluation of a Navigation Intervention for People with Cancer in Old Age and their Family Caregivers: an international pragmatic randomized controlled trial
HORIZON.2.1101057361
€59,932
P
First line randomized study platform to optimize treatment in patients with metastatic renal cell carcinoma
Health101104801
€55,777
P
A PRAGMATIC CLINICAL STUDY OF NEOADJUVANT CHEMOTHERAPY FOLLOWED BY SURGERY VERSUS SURGERY ALONE FOR PATIENTS WITH HIGH RISK RETROPERITONEAL SARCOMA
Health101103843
€49,719
P
Developing and implementing innovative Patient-Centred Care Pathways for cancer patients
Health101057514
€47,735
P
FCAECC Fellowship programme for talented researchers in cancer
MSCA (Marie Skłodowska-Curie)101081298
€42,984
C
Risk assessment Tools for severe side Effects after breasT Radiotherapy: radiation safety through biological extended models and dIgital twinS
Nuclear Research (Euratom)101166699
€34,932
P
On-chip tomographic microscopy: a paraDIgm Shift for RevolUtionizing lab-on-a-chiP bioimaging technology
HORIZON.3.1101099663
€30,183
P
Bone Marrow-on-Chip as smart sensor of lung cancer relapse
HORIZON.3.1101130604
€29,998
P
INtegrated Short-term PallIative REhabilitation to improve quality of life and equitable care access in incurable cancer
Health101057043
€27,253
P
Making patient-derived tumor organoids a reliable cancer therapy testing platform
MSCA (Marie Skłodowska-Curie)101236487
€2,455